Buy Zycan Online
Zycan Injection is a veterinary medicine containing polysulfated glycosaminoglycan (PSGAG), approved for the treatment of lameness due to degenerative aseptic joint disease (osteoarthritis) in horses. It is essentially the first registered generic alternative to Adequan® Injection.
Key Facts About Zycan Injection
- Active ingredient: Polysulfated Glycosaminoglycan (PSGAG) 100 mg/ml
- Form: Injectable solution (5 ml vials, typically packaged 7 per carton)
- Indication: Treatment of degenerative joint disease (DJD) and osteoarthritis in horses
- Approval: APVMA Approval No. 87359 (Australia)
- Prescription status: Prescription‑only veterinary medicine
Benefits
- Joint protection: Helps prevent, retard, or reverse cartilage lesions associated with osteoarthritis.
- Anti‑inflammatory: Inhibits enzymes that degrade cartilage and joint fluid.
- Stimulates repair: Encourages synthesis of glycosaminoglycans and hyaluronic acid for joint lubrication.
- Versatile use: Recommended for preventative treatment, chronic joint maintenance, and post‑operative care.
Dosage & Administration
- Route: Intramuscular injection in horses.
- Typical regimen: Often given as a series of injections (e.g., weekly for 4 weeks), depending on veterinary guidance.
- Safety: Must be administered by a veterinarian; follow product label instructions carefully.
Storage & Handling
- Store below 25 °C.
- Protect from light.
- Keep out of reach of children.
Comparison With Other Equine OA Treatments
| Feature | Zycan (PSGAG) | Adequan (PSGAG) | Legend (HA) |
|---|---|---|---|
| Active ingredient | PSGAG 100 mg/ml | PSGAG 100 mg/ml | Hyaluronate sodium |
| Form | Injectable solution | Injectable solution | Injectable solution |
| Indication | Osteoarthritis, DJD | Osteoarthritis, DJD | Joint inflammation |
| FDA/APVMA Approval | APVMA (Australia) | FDA (USA) | FDA (USA) |
| Mechanism | Protects cartilage, stimulates repair | Same | Lubricates joints, reduces inflammation |
| Use cases | Preventative, chronic, post‑surgery | Same | Short‑term relief |
Risks & Considerations
- Prescription required — not available over the counter.
- Side effects: Mild injection site swelling or transient fever.
- Not for food animals — approved only for horses.
- Competition rules: Always check racing regulations before use.
Availability
- Pack size: 7 × 5 ml vials per carton.
- Markets: Approved in Australia; available internationally through veterinary suppliers.
- Pricing: Varies by supplier, typically comparable to Adequan generics.
Zycan Injection is a cost‑effective, APVMA‑approved alternative to Adequan® for managing osteoarthritis in horses. It offers joint protection, anti‑inflammatory benefits, and cartilage repair support, making it valuable for preventative care, chronic maintenance, and post‑operative recovery. For your website Vet Supply Hub, positioning Zycan as a trusted equine joint therapy with global availability will help attract buyers in the USA, UK, Canada, Australia, Germany, France, Switzerland, Spain, Portugal, and other European countries.
Zycan is a Disease Modifying Osteoarthritis Drug (DMOAD) for the treatment and prevention of clinical signs attributable to degenerative and/or traumatic aseptic joint disease in horses. DMOADs are intended to prevent, retard or reverse the
morphologic cartilaginous lesions associated with degenerative joint disease (DJD).
PSGAGs, such as Zycan have been advocated for the (i) preventative treatment of joint disease (ii) chronic joint maintenance programs and (iii) post-operative care of horses returning to training following joint surgery.High Performance Joint and Bone Therapies. Back to Veterinary Medicines. Zycan Injection. For treatment of lameness due to degenerative aseptic joint. Statement of Hazardous Nature
This product is classified as: Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code,
IATA or IMDG/IMSBC criteria.
SUSMP Classification: None allocated.
ADG Classification: None allocated. Not a Dangerous Good according to Australian Dangerous Goods (ADG)
Code, IATA or IMDG/IMSBC criteria.
UN Number: None allocated.
GHS Signal word: NONE. Not hazardous.
PREVENTION
P102: Keep out of reach of children.
P262: Do not get in eyes, on skin, or on clothing.
P264: Wash contacted areas thoroughly after handling.
P281: Use personal protective equipment as required.
RESPONSE
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P370+P378: Not combustible. Use extinguishing media suited to burning materials.
STORAGE
P403: Store in a well-ventilated place.
P410: Protect from sunlight.
P411: Store at temperatures not exceeding 25°C.
P402+P404: Store in a dry place. Store in a closed container.
DISPOSAL
P501: Dispose of small quantities and empty containers by wrapping with paper and putting in garbage.
For larger quantities, if recycling or reclaiming is not possible, use a commercial waste disposal service.
EMERGENCY OVERVIEW
Physical Description & Colour: Clear pale straw-coloured liquid.
Odour: Mild odour.
Major Health Hazards: no significant risk factors have been found for this product.
Reviews
There are no reviews yet.